The DOI matches its Crossref record; 58 of the 58 references it cites were found in a registry or an index.
High CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritis
Open accessAbstract
To improve our knowledge on the pathophysiology of rheumatoid arthritis (RA), we investigated gene expression patterns in synovial tissue from RA and osteoarthritis (OA) patients. DNA oligonucleotide microarray analysis was employed to identify differentially expressed genes in synovial tissue from pathologically classified tissue samples from RA (n = 20) and OA patients (n = 10). From 7131 gene sets displayed on the microarray chip, 101 genes were found to be upregulated and 300 genes to be downregulated in RA as compared with OA. Semiquantitative reverse-transcription polymerase chain reaction, Western blotting and immunohistochemistry were used to validate microarray expression levels. These experiments revealed that Cys-X-Cys receptor (CXCR)1, CXCR2 and CXCR3 mRNAs, as well as Cys-X-Cys ligand (CXCL)9 (monokine induced by IFN-gamma) and CXCL10 (IFN-gamma inducible protein 10) mRNAs, were significantly upregulated in RA as compared with OA disease. Elevated protein levels in RA synovial tissue were detected for CXCR1 and CXCR3 by Western blotting. Using immunohistochemistry, CXCR3 protein was found to be preferentially expressed on mast cells within synovial tissue from RA patients. These findings suggest that substantial expression of CXCR3 protein on mast cells within synovial tissue from RA patients plays a significant role in the pathophysiology of RA, accompanied by elevated levels of the chemokines CXCL9 and CXCL10. Mature mast cells are likely to contribute to and sustain the inflamed state in arthritic lesions (e.g. by production of inflammatory mediators such as histamine, proteinases, arachidonic acid metabolites and cytokines). Thus, the mast cell could become a potential target in therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arnett, F. C., Edworthy, S. M., Bloch, D. A., Mcshane, D. J., Fries, J. F., Cooper, N. S., Healey, L. A., Kaplan, S. R., Liang, M. H., Luthra, H. S., et al. (1988) · Arthritis & Rheumatism · doi:10.1002/art.1780310302 · Cited by 19,752
Revised Criteria for the Classification of Rheumatoid Arthritis
Arnett, F. C. (1990) · Orthopaedic Nursing · doi:10.1097/00006416-199003000-00011 · Cited by 7,723
Traffic signals for lymphocyte recirculation and leukocyte emigration: The multistep paradigm
Springer, T. A. (1994) · Cell · doi:10.1016/0092-8674(94)90337-9 · Cited by 6,929
Baggiolini, M., Dewald, B., & Moser, B. (1997) · Annual Review of Immunology · doi:10.1146/annurev.immunol.15.1.675 · Cited by 2,192
Bonecchi, R., Bianchi, G., Bordignon, P. P., D'Ambrosio, D., Lang, R., Borsatti, A., Sozzani, S., Allavena, P., Gray, P. A., Mantovani, A., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.1.129 · Cited by 2,014
ARTHRITIS AND ALLIED CONDITIONS
BERNARD I. COMROE, T. L., & HOLLANDER, J. L. (1949) · The American Journal of the Medical Sciences · doi:10.1097/00000441-194911000-00026 · Cited by 1,581
Flexible Programs of Chemokine Receptor Expression on Human Polarized T Helper 1 and 2 Lymphocytes
Sallusto, F., Lenig, D., Mackay, C. R., & Lanzavecchia, A. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.187.6.875 · Cited by 1,542
Qin, S., Rottman, J. B., Myers, P., Kassam, N., Weinblatt, M., Loetscher, M., Koch, A. E., Moser, B., & Mackay, C. R. (1998) · Journal of Clinical Investigation · doi:10.1172/jci1422 · Cited by 1,359
Loetscher, M., Gerber, B., Loetscher, P., Jones, S. A., Piali, L., Clark-Lewis, I., Baggiolini, M., & Moser, B. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.963 · Cited by 1,193
Selective Expression of the Eotaxin Receptor CCR3 by Human T Helper 2 Cells
Sallusto, F., Mackay, C. R., & Lanzavecchia, A. (1997) · Science · doi:10.1126/science.277.5334.2005 · Cited by 1,050
New Concepts about the Mast Cell
Flier, J. S., Underhill, L. H., & Galli, S. J. (1993) · New England Journal of Medicine · doi:10.1056/nejm199301283280408 · Cited by 990
Chemokine receptors and their role in inflammation and infectious diseases
Murdoch, C., & Finn, A. (2000) · Blood · doi:10.1182/blood.v95.10.3032 · Cited by 839
Taub, D. D., Lloyd, A. R., Conlon, K., Wang, J. M., Ortaldo, J. R., Harada, A., Matsushima, K., Kelvin, D. J., & Oppenheim, J. J. (1993) · The Journal of experimental medicine · doi:10.1084/jem.177.6.1809 · Cited by 752
Mast Cells: A Cellular Link Between Autoantibodies and Inflammatory Arthritis
Lee, D. M., Friend, D. S., Gurish, M. F., Benoist, C., Mathis, D., & Brenner, M. B. (2002) · Science · doi:10.1126/science.1073176 · Cited by 750
P- and E-selectin mediate recruitment of T-helper-1 but not T-helper-2 cells into inflamed tissues
Austrup, F., Vestweber, D., Borges, E., Löhning, M., Bräuer, R., Herz, U., Renz, H., Hallmann, R., Scheffold, A., Radbruch, A., et al. (1997) · Nature · doi:10.1038/385081a0 · Cited by 725
Discovery and analysis of inflammatory disease-related genes using cDNA microarrays
Heller, R. A., Schena, M., Chai, A., Shalon, D., Bedilion, T., Gilmore, J., Woolley, D. E., & Davis, R. W. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.6.2150 · Cited by 721
Imai, T., Nagira, M., Takagi, S., Kakizaki, M., Nishimura, M., Wang, J., Gray, P. W., Matsushima, K., & Yoshie, O. (1999) · International Immunology · doi:10.1093/intimm/11.1.81 · Cited by 720
Biochemical characterization of a gamma interferon-inducible cytokine (IP-10).
Luster, A. D., & Ravetch, J. V. (1987) · The Journal of experimental medicine · doi:10.1084/jem.166.4.1084 · Cited by 666
Lymphotactin: a Cytokine that Represents a New Class of Chemokine
Kelner, G. S., Kennedy, J., Bacon, K. B., Kleyensteuber, S., Largaespada, D. A., Jenkins, N. A., Copeland, N. G., Bazan, J. F., Moore, K. W., Schall, T. J., et al. (1994) · Science · doi:10.1126/science.7973732 · Cited by 648
Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation
Kitamura, Y., Go, S., & Hatanaka, K. (1978) · Blood · doi:10.1182/blood.v52.2.447.447 · Cited by 608
Kirshenbaum, A. S., Goff, J. P., Semere, T., Foster, B., Scott, L. M., & Metcalfe, D. D. (1999) · Blood · doi:10.1182/blood.v94.7.2333.419k30_2333_2342 · Cited by 420
Arthritis and Allied Conditions
Swannell, A. J. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.10.702 · Cited by 393
Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization
Loetscher, M., Loetscher, P., Brass, N., Meese, E., & Moser, B. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199811)28:11<3696::aid-immu3696>3.0.co;2-w · Cited by 357
Saarinen, J., Kalkkinen, N., Welgus, H. G., & Kovanen, P. T. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)32427-4 · Cited by 315
Gay, S., Gay, R. E., & Koopman, W. J. (1993) · Annals of the Rheumatic Diseases · doi:10.1136/ard.52.suppl_1.s39 · Cited by 262
Cutting Edge: T Helper 1 and T Helper 2 Cells Respond Differentially to Chemokines
Siveke, J. T., & Hamann, A. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.2.550 · Cited by 257
Pitzalis, C., Kingsley, G., Haskard, D., & Panayi, G. (1988) · European Journal of Immunology · doi:10.1002/eji.1830180915 · Cited by 232
Critical Role for CXCR3 Chemokine Biology in the Pathogenesis of Bronchiolitis Obliterans Syndrome
Belperio, J. A., Keane, M. P., Burdick, M. D., Lynch, J. P., Xue, Y. Y., Li, K., Ross, D. J., & Strieter, R. M. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.2.1037 · Cited by 230
Interleukin-8 Stimulates Calcium Transients and Promotes Epidermal Cell Proliferation
Tuschil, A., Lam, C., Haslberger, A., & Lindley, I. (1992) · Journal of Investigative Dermatology · doi:10.1111/1523-1747.ep12616634 · Cited by 226
Piali, L., Weber, C., LaRosa, G., Mackay, C. R., Springer, T. A., Clark-Lewis, I., & Moser, B. (1998) · European Journal of Immunology · doi:10.1002/(sici)1521-4141(199803)28:03<961::aid-immu961>3.0.co;2-4 · Cited by 224
Tetlow, L. C., & Woolley, D. E. (1995) · Annals of the Rheumatic Diseases · doi:10.1136/ard.54.11.896 · Cited by 194
HuMig: A New Human Member of the Chemokine Family of Cytokines
Farber, J. M. (1993) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1993.1403 · Cited by 188
LEES, M., TAYLOR, D. J., & WOOLLEY, D. E. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18980.x · Cited by 178
Mast cell activation and migration to lymph nodes during induction of an immune response in mice.
Wang, H. W., Tedla, N., Lloyd, A. R., Wakefield, D., & McNeil, P. H. (1998) · Journal of Clinical Investigation · doi:10.1172/jci3704 · Cited by 173
Quantitation of human synovial mast cells in rheumatoid arthritis and other rheumatic diseases
Godfrey, H. P., Ilardi, C., Engber, W., & Graziano, F. M. (1984) · Arthritis & Rheumatism · doi:10.1002/art.1780270803 · Cited by 172
García-López, M. Á., Sánchez-Madrid, F., Rodríguez-Frade, J. M., Mellado, M., Acevedo, A., García, M. I., Albar, J. P., Martínez-A, C., & Marazuela, M. (2001) · Laboratory Investigation · doi:10.1038/labinvest.3780248 · Cited by 169
Jinquan, T., Jing, C., Jacobi, H. H., Reimert, C. M., Millner, A., Quan, S., Hansen, J. B., Dissing, S., Malling, H.-J., Skov, P. S., et al. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.165.3.1548 · Cited by 169
Distribution, activation and tryptase/chymase phenotype of mast cells in the rheumatoid lesion.
Tetlow, L. C., & Woolley, D. E. (1995) · Annals of the Rheumatic Diseases · doi:10.1136/ard.54.7.549 · Cited by 153
The role of chemokines in inflammatory joint disease
Kunkel, S. L., Lukacs, N. W., Kasama, T., & Strieter, R. M. (1996) · Journal of Leukocyte Biology · doi:10.1002/jlb.59.1.6 · Cited by 143
Selective accumulation of CCR5+ T lymphocytes into inflamed joints of rheumatoid arthritis
Suzuki, N., Nakajima, A., Yoshino, S., Matsushima, K., Yagita∥, H., & Okumura, K. (1999) · International Immunology · doi:10.1093/intimm/11.4.553 · Cited by 140
Targeting the Function of IFN-γ-Inducible Protein 10 Suppresses Ongoing Adjuvant Arthritis
Salomon, I., Netzer, N., Wildbaum, G., Schif‐Zuck, S., Maor, G., & Karin, N. (2002) · The Journal of Immunology · doi:10.4049/jimmunol.169.5.2685 · Cited by 132
Gotis‐Graham, I., & McNeil, H. P. (1997) · Arthritis & Rheumatism · doi:10.1002/art.1780400314 · Cited by 128
IL-8 specifically binds to endothelial but not to smooth muscle cells.
Schönbeck, U., Brandt, E., Petersen, F., Flad, H.-D., & Loppnow, H. (1995) · The Journal of Immunology · doi:10.4049/jimmunol.154.5.2375 · Cited by 125
Increased expression of epidermal IL-8 receptor in psoriasis. Down-regulation by FK-506 in vitro.
Schulz, B., Michel, G., Wagner, S. N., Süss, R., Beetz, A., Peter, R. U., Kemény, L. V., & Ruzicka, T. (1993) · The Journal of Immunology · doi:10.4049/jimmunol.151.8.4399 · Cited by 120
Kraan, M. C., Patel, D. D., Haringman, J. J., Smith, M., Weedon, H., Ahern, M. J., Breedveld, F. C., & Tak, P. P. (2000) · Arthritis Research & Therapy · doi:10.1186/ar141 · Cited by 113
New concepts about the mast cell
Galli, S. J. (1994) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(94)90322-0 · Cited by 94
Konttinen, Y. T., Reitamo, S., Ranki, A., Häyry, P., Kankaanapää, U., & Wegelius, O. (1981) · Arthritis & Rheumatism · doi:10.1002/art.1780240112 · Cited by 90
Through the looking glass: the diverse in vivo activities of chemokines
Kunkel, S. L. (1999) · Journal of Clinical Investigation · doi:10.1172/jci8511 · Cited by 85
Dolhain, R. J. E. M., ter Haar, N. T., Hoefakker, S., Tak, P. P., LEY, M. D., Claassen, E., Breedveld, F. C., & Miltenburg, A. M. M. (1996) · Lara D. Veeken · doi:10.1093/rheumatology/35.1.24 · Cited by 75
Pathogenesis of juvenile chronic arthritis: genetic and environmental factors
Murray, K. J., THOMPSON, S. D., & Glass, D. N. (1997) · Archives of Disease in Childhood · doi:10.1136/adc.77.6.530 · Cited by 54
Molecular and cellular interactions in rheumatoid synovium
Müller‐Ladner, U. (1996) · Current Opinion in Rheumatology · doi:10.1097/00002281-199605000-00008 · Cited by 40
Ruschpler, P., & Stiehl, P. (2002) · PubMed · Cited by 34
Self-citationChemokines and their role in disease
Lukacs, N. W., & Kunkel, S. L. (1998) · International Journal of Clinical & Laboratory Research · doi:10.1007/s005990050025 · Cited by 22
Mast Cells as a Target of Rheumatoid Arthritis Treatment
Kobayashi, Y., & Okunishi, H. (2002) · The Japanese Journal of Pharmacology · doi:10.1254/jjp.90.7 · Cited by 18
Mast cells in the rheumatoid lesion–ringleaders or innocent bystanders?
Wooley, D. E. (1995) · Annals of the Rheumatic Diseases · doi:10.1136/ard.54.7.533 · Cited by 16
Shikata, A., Shikata, T., Sotozono, Y., Hosoi, H., Matsumura, T., Sugimoto, T., & Sawada, T. (2000) · Medical and Pediatric Oncology · doi:10.1002/(sici)1096-911x(200006)34:6<438::aid-mpo12>3.0.co;2-q · Cited by 14
Romas (2000) · Pure Amsterdam UMC · doi:10.1002/1529-0131(200004)43:4
Komuro (2001) · doi:10.1002/1529-0131(200112)44:12
Cited by
CXCR3 ligands in disease and therapy
Van Raemdonck, K., Van den Steen, P. E., Liekens, S., Van Damme, J., & Struyf, S. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2014.11.009 · Cited by 310
Woetzel, D., Huber, R., Kupfer, P., Pohlers, D., Pfaff, M., Driesch, D., Häupl, T., Koczan, D., Stiehl, P., Guthke, R., et al. (2014) · Arthritis Research & Therapy · doi:10.1186/ar4526 · Cited by 276
Self-citationNakamura, N., Shimaoka, Y., Tougan, T., Onda, H., Okuzaki, D., Zhao, H., Fujimori, A., Yabuta, N., Nagamori, I., Tanigawa, A., et al. (2006) · DNA Research · doi:10.1093/dnares/dsl006 · Cited by 94
Metadata
- Authors
- Ruschpler, P., Lorenz, P., Eichler, W., Koczan, D., Hänel, C., Scholz, R., Melzer, C., Thiesen, H.-J., & Stiehl, P.
- Venue
- Arthritis Res Ther
- Published
- 2003-06-26
- Volume
- 5
- Issue
- 5
- Pages
- R241-52
- ISSN
- 1478-6354 (ISSN-L)
- OpenAlex
- W1489255503
- Cited by
- 292
- References
- 58
- FWCI
- 41.41
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.